Bronnen:
- Fukudo S, Endo Y, Hongo M et al. Safety and efficacy of the sodium-glucose cotransporter 1 inhibitor mizagliflozin for functional constipation: a randomised, placebo-controlled, double-blind phase 2 trial. The Lancet Gastroenterology&Hepatology. DOI:https://doi.org/10.1016/S2468-1253(18)30165-1.